Valeritas Holdings (VLRX) Inventory Turnover Ratio, from third quarter 2019 to third quarter 2018, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Valeritas Holdings Inc.  (VLRX)
 

Valeritas Holdings Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2019, Valeritas Holdings's inventory turnover ratio sequentially decreased to 1.89 in the third quarter 2019, otherwise the ratio remained above the average, as VLRX's markets remain strong.Valeritas Holdings's average inventory processing period in the Sep 30 2019 quarter, has increased to 193 days, from 188 days, in the Jun 30 2019 quarter.

Within Healthcare sector 289 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2019, to 1814, from total ranking in the second quarter 2019 at 1818.

VLRX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Valeritas Holdings Inc. Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VLRX Inventory Turnover Ratio (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Inventory Growth 29.15 % 22.3 % -4.56 % -15.81 % -19.87 %
Y / Y Cost of Sales Growth 13.74 % 11.48 % 5.46 % 14.74 % 23 %
Inventory Turnover Ratio (TTM) 1.89 1.94 2 1.95 1.8
VLRX's Total Ranking # 1814 # 1818 # 1833 # 1811 #
Average inventory processing period 193 188 183 188 203
Seq. Inventory Growth 0.62 % 10.67 % 13.99 % 1.74 % -4.72 %
Seq. Cost of Sales Growth 12.33 % 13.04 % -7.65 % -3.01 % 10.1 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 118
Healthcare Sector # 290
Overall Market # 1814

Inventory Turnover Ratio Statistics
High Average Low
2 1.37 0
(Mar 31 2019)   (Dec 31 2014)



VLRX Company Profile >> Back to VLRX Efficiency Comparisons >> Compare VLRX Inventory Turnover Ratio to its Competitors

Financial Statements
Valeritas Holdings's Inventories $ 9 Millions Visit VLRX's Balance sheet
Valeritas Holdings's Cost of Revenues TTM $ 15 Millions Visit VLRX's Income Statement
What are VLRX's Sales? Visit VLRX's Sales by Segment

Other Inventory Turnover Ratios
Valeritas Holdings's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
VLRX's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for VLRX's Competitors
Inventory Turnover Ratio for VLRX's Suppliers
Inventory Turnover Ratio for VLRX's Customers

You may also want to know
VLRX's Sales Growth Rates VLRX's Pe Price to earnings ratio VLRX's Receivables Turnover Ratio VLRX's Stock Quote
VLRX's Net Income Growth Rates VLRX's Ps Price to Sales ratio VLRX's Sales per Employee VLRX's Asset Turnover Ratio
VLRX's Net Margin VLRX's Pb Price to Book ratio VLRX's Financial Strength Ratios VLRX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2019, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2019 Inventories at quarter ending Sep 30 2019
Quorum Health Corporation  4.76 $ 202.419  Millions$ 43  Millions
Dmk Pharmaceuticals Corporation  4.74 $ 14.324  Millions$ 3  Millions
Nanomix Corp  4.73 $ 0.025  Millions$ 0  Millions
Rvl Pharmaceuticals Plc  4.72 $ 126.747  Millions$ 27  Millions
Myriad Genetics Inc   4.70 $ 147.600  Millions$ 31  Millions
Co diagnostics Inc   4.46 $ 0.069  Millions$ 0  Millions
Aptevo Therapeutics Inc   4.39 $ 22.568  Millions$ 5  Millions
Integrated Biopharma Inc  4.38 $ 44.677  Millions$ 10  Millions
Msa Safety Inc  4.27 $ 756.357  Millions$ 177  Millions
Premier Biomedical Inc  4.26 $ 0.099  Millions$ 0  Millions
Prophase Labs Inc   4.24 $ 7.868  Millions$ 2  Millions
Igc Pharma Inc   4.24 $ 6.156  Millions$ 1  Millions
Integer Holdings Corporation  4.18 $ 790.985  Millions$ 189  Millions
Abbvie Inc   4.18 $ 7,455.000  Millions$ 1,783  Millions
Organogenesis Holdings Inc   4.16 $ 73.067  Millions$ 18  Millions
Stereotaxis Inc   4.15 $ 5.820  Millions$ 1  Millions
Tactile Systems Technology Inc   4.09 $ 53.726  Millions$ 13  Millions
Aerie Pharmaceuticals Inc   4.07 $ 46.188  Millions$ 11  Millions
Conformis inc   4.03 $ 41.640  Millions$ 10  Millions
Exact Sciences Corporation  4.01 $ 185.401  Millions$ 46  Millions
Bionano Genomics Inc   3.99 $ 8.066  Millions$ 2  Millions
Neurometrix Inc   3.94 $ 8.363  Millions$ 2  Millions
3m Company  3.92 $ 16,871.000  Millions$ 4,303  Millions
Dynatronics Corporation  3.89 $ 43.108  Millions$ 11  Millions
Enovis Corp  3.88 $ 2,341.714  Millions$ 604  Millions
Dentsply Sirona Inc   3.85 $ 2,340.100  Millions$ 608  Millions
Varian Medical Systems Inc   3.84 $ 1,947.200  Millions$ 507  Millions
Kaya Holdings Inc   3.82 $ 0.474  Millions$ 0  Millions
Reliv International Inc  3.82 $ 9.821  Millions$ 3  Millions
Verastem Inc   3.80 $ 1.334  Millions$ 0  Millions

Date modified: 2026-09-02T19:58:11+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.